Efficacia del Levetiracetam a lungo termine nel trattamento delle epilessie sintomatiche farmacoresistenti

M. Elia; M. Bottitta; G. Calabrese; S. Romano; S. A. Musumeci

Efficacia del Levetiracetam a lungo termine nel trattamento delle epilessie sintomatiche farmacoresistenti

Translated title of the contribution: Efficacy of Levetiracetam in the long-term treatment of drug-resistant symptomatic epilepsies

M. Elia, M. Bottitta, G. Calabrese, S. Romano, S. A. Musumeci

www.irccs.oasi.en.it

Research output: Contribution to journal › Article › peer-review

Abstract

In this open label study we evaluated the efficacy of Levetiracetam (LEV) in the long-term treatment of 15 patients (7 males, 8 females, age range 4-40 years, mean 22.53 years) with drug-resistant symptomatic epilepsies. Our data showed that LEV is an efficacious and safe antieplleptic drug in this group of subjects.

Translated title of the contribution	Efficacy of Levetiracetam in the long-term treatment of drug-resistant symptomatic epilepsies
Original language	Italian
Pages (from-to)	197-199
Number of pages	3
Journal	Bollettino - Lega Italiana contro l'Epilessia
Issue number	129-130
Publication status	Published - 2005

ASJC Scopus subject areas

Clinical Neurology

Cite this

@article{28092dcd0690441eb5f3aec6d48071c8,

title = "Efficacia del Levetiracetam a lungo termine nel trattamento delle epilessie sintomatiche farmacoresistenti",

abstract = "In this open label study we evaluated the efficacy of Levetiracetam (LEV) in the long-term treatment of 15 patients (7 males, 8 females, age range 4-40 years, mean 22.53 years) with drug-resistant symptomatic epilepsies. Our data showed that LEV is an efficacious and safe antieplleptic drug in this group of subjects.",

keywords = "Antiepileptic drugs, Drug resistance, Levetiracetam, Symptomatic epilepsies",

author = "M. Elia and M. Bottitta and G. Calabrese and S. Romano and Musumeci, {S. A.}",

year = "2005",

language = "Italian",

pages = "197--199",

journal = "Bollettino - Lega Italiana contro l'Epilessia",

issn = "0394-560X",

publisher = "Lega Italiana contro l'Epilessia",

number = "129-130",

}

TY - JOUR

T1 - Efficacia del Levetiracetam a lungo termine nel trattamento delle epilessie sintomatiche farmacoresistenti

AU - Elia, M.

AU - Bottitta, M.

AU - Calabrese, G.

AU - Romano, S.

AU - Musumeci, S. A.

PY - 2005

Y1 - 2005

N2 - In this open label study we evaluated the efficacy of Levetiracetam (LEV) in the long-term treatment of 15 patients (7 males, 8 females, age range 4-40 years, mean 22.53 years) with drug-resistant symptomatic epilepsies. Our data showed that LEV is an efficacious and safe antieplleptic drug in this group of subjects.

AB - In this open label study we evaluated the efficacy of Levetiracetam (LEV) in the long-term treatment of 15 patients (7 males, 8 females, age range 4-40 years, mean 22.53 years) with drug-resistant symptomatic epilepsies. Our data showed that LEV is an efficacious and safe antieplleptic drug in this group of subjects.

KW - Antiepileptic drugs

KW - Drug resistance

KW - Levetiracetam

KW - Symptomatic epilepsies

UR - http://www.scopus.com/inward/record.url?scp=33645216152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645216152&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:33645216152

SP - 197

EP - 199

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

SN - 0394-560X

IS - 129-130

ER -

Efficacia del Levetiracetam a lungo termine nel trattamento delle epilessie sintomatiche farmacoresistenti

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this